Key facts
- It has raised $830.0M across 1 recorded rounds; the latest was PE Growth/Expansion ($830.0M) in May 2021.
- 5 institutional filers report fund marks on Caris Life Sciences across 56 filings.
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for Caris Life Sciences
Create free account
No card required
Funding rounds
1 roundsMay 2021PE Growth/Expansion$830.0M▮
About Caris Life Sciences
- Industry
- Biotechnology
PA Mark — not yet priced
Caris Life Sciences doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in Caris Life Sciences shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
5 filers · latest Jun 20265 SEC-registered funds reported 56 fair-value marks on Caris Life Sciences between Apr 2025 and Jun 2026. Filer-level marks and implied $/share are available to Pro members.